Rheumatology Advance Access originally published online on November 22, 2007
Rheumatology 2008 47(1):103-104; doi:10.1093/rheumatology/kem259
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
LETTERS TO THE EDITOR |
The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function
Roche Palo Alto, Palo Alto, CA, USA
Correspondence to: S. L. Peng, 3431 Hillview Ave., M/S A2-259, Palo Alto, CA 94304, USA. E-mail: stanford.peng@roche.com
| The first 10% of the full text of this article appears below. |
SIR, The transcriptional modulator Ifi202 has been implicated in the pathogenesis of lupus via genetic studies in the vicinity of the Nba2 locus [1]. It is a member of the interferon-inducible Ifi200 cluster of genes located on mouse chromosome 1, which bears homology to a cluster of three human chromosome 1 genes (MNDA, IFI 16 and AIM2 [2]), all of which share a largely conserved
200 amino acid domain and have been implicated in multiple cellular processes, including cellular proliferation and apoptosis, by
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Choubey Comment on: The candidate lupus susceptibility gene Ifi202a is largely dispensable for B-cell function Rheumatology, April 1, 2008; 47(4): 558 - 559. [Full Text] [PDF] |
||||
